Senhwa Biosciences, Inc.
Clinical trials sponsored by Senhwa Biosciences, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug targets Hard-to-Treat cancers in people with BRCA2 or PALB2 mutations Results expected Mar 2027 (estimated)